Literature DB >> 20714682

Biphasic effects of ankaferd blood stopper on renal tubular apoptosis in the rat partial nephrectomy model representing distinct levels of hemorrhage.

Emre Huri1, Ibrahim C Haznedaroglu, Turgay Akgul, Muzeyyen Astarci, Huseyin Ustun, Cankon Germiyanoulu.   

Abstract

OBJECTIVE: To investigate the effect of Ankaferd Blood Stopper (ABS), on renal tubular apoptosis and on expressions of endothelial nitric oxide synthase (eNOS), inducible nitric oxide synthase (iNOS), and apoptosis protease-activating factor-1 (Apaf-1) in the ipsilateral kidney after an experimentally formed partial nephrectomy in a rat model.
METHODS: The study was performed in 2009 at the Ankara Training and Research Hospital, Animal Laboratory Center, Ankara, Turkey. We divided 24 Wistar rats into the following 4 groups. Group I (GI) - partial nephrectomy (PN) with hilar control as the conventional technique, Group II (GII)-the conventional technique with ABS, Group III (GIII) - received ABS application to the renal parenchyma and collecting duct with hilar control (non-sutured group). Group IV (GIV) - PN and ABS were performed without hilar control. The ABS solution (1 cc) was applied during the surgery to stop bleeding from resected renal tissue. At first month, all rats were sacrificed. Renal tubular apoptosis was investigated.
RESULTS: The mean percentage of apoptotic cell counts in GI were 20% iNOS, 20% eNOS, and 10% Apaf-1. In GII they were 10% iNOS, 20% eNOS, 5% Apaf-1, in GIII they were 40% iNOS, 50% eNOS, 30% Apaf-1, and in GIV they were 5% iNOS, 5% eNOS, and 3% Apaf-1. There was no significant decrease in apoptotic cells in GII, GIII, and GIV, to which we applied ABS. The highest percentage of apoptosis was shown in GIII accompanied by significant inflammation. The lowest percentage was determined in GIV, the non-warm ischemia group. The ABS has a dual biphasic de novo effects on apoptosis.
CONCLUSION: The challenge of severe hemorrhage in the renal tubular cellular micro-environment causes ABS-induced down-regulations in the expressions of apoptotic molecules, indicating that ABS may act as a topical biological response modifier.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20714682

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  9 in total

1.  Ankaferd hemostat in the management of gastrointestinal hemorrhages.

Authors:  Yavuz Beyazit; Murat Kekilli; Ibrahim C Haznedaroglu; Ertugrul Kayacetin; Metin Basaranoglu
Journal:  World J Gastroenterol       Date:  2011-09-21       Impact factor: 5.742

2.  Treatment of hemorrhagic gastritis by Ankaferd blood stopper versus Omeprazole: experimental randomized rat models.

Authors:  Hikmetullah Batgi; Erdem Akbal; Erdem Koçak; Ömer Akyürek; Seyfettin Köklü; Melahat Dönmez; Fahri Güneş
Journal:  Wien Klin Wochenschr       Date:  2015-04-10       Impact factor: 1.704

3.  Ankaferd blood stopper is more effective than adrenaline plus lidocaine and gelatin foam in the treatment of epistaxis in rabbits.

Authors:  Mehmet Kelles; M Tayyar Kalcioglu; Emine Samdanci; Erol Selimoglu; Mustafa Iraz; Murat Cem Miman; Ibrahim C Haznedaroglu
Journal:  Curr Ther Res Clin Exp       Date:  2011-10

4.  Qualitative/Chemical Analyses of Ankaferd Hemostat and Its Antioxidant Content in Synthetic Gastric Fluids.

Authors:  Ahmet Koluman; Nejat Akar; Umit Y Malkan; Ibrahim C Haznedaroglu
Journal:  Biomed Res Int       Date:  2016-01-26       Impact factor: 3.411

5.  Growth inhibitory activity of Ankaferd hemostat on primary melanoma cells and cell lines.

Authors:  Seyhan Turk; Umit Yavuz Malkan; Mehdi Ghasemi; Helin Hocaoglu; Duygu Mutlu; Gursel Gunes; Salih Aksu; Ibrahim Celalettin Haznedaroglu
Journal:  SAGE Open Med       Date:  2017-02-10

Review 6.  Antineoplastic Effects of Ankaferd Hemostat.

Authors:  Umit Yavuz Malkan; Ibrahim Celalettin Haznedaroglu
Journal:  Biomed Res Int       Date:  2022-08-02       Impact factor: 3.246

7.  Effect of ankaferd blood stopper in experimental peritoneal adhesion model.

Authors:  Gokhan Karaca; Oktay Aydin; Faruk Pehlivanli; Ahmet Kocael; Recep Pekcici; Esat Duymus; Sukran Akgedik; Osman Guler
Journal:  Ann Surg Treat Res       Date:  2016-03-30       Impact factor: 1.859

8.  Comparison of the Efficiencies of Buffers Containing Ankaferd and Chitosan on Hemostasis in an Experimental Rat Model with Femoral Artery Bleeding.

Authors:  Serkan Abacıoğlu; Kemal Aydın; Fatih Büyükcam; Ural Kaya; Bahattin Işık; Muhammed Evvah Karakılıç
Journal:  Turk J Haematol       Date:  2015-04-27       Impact factor: 1.831

Review 9.  Pharmacobiological management of hemostasis within clinical backgrounds via Ankaferd hemostat (Ankaferd blood stopper).

Authors:  Rafiye Ciftciler; Ali Erdinc Ciftciler; Umit Yavuz Malkan; Ibrahim C Haznedaroglu
Journal:  SAGE Open Med       Date:  2020-02-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.